March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
A Role For Complement Activation In Preventing Retinal Degeneration
Author Affiliations & Notes
  • Minzhong Yu
    Cole Eye Institute,
    Cleveland Clinic Foundation, Cleveland, Ohio
  • Weilin Zou
    Department of Cell Biology, Lerner Research Institute,
    Cleveland Clinic Foundation, Cleveland, Ohio
  • Neal S. Peachey
    Cole Eye Institute,
    Cleveland Clinic Foundation, Cleveland, Ohio
    Research Service, Louis Stokes VA Medical Center, Cleveland, Ohio
  • Thomas McIntyre
    Department of Cell Biology, Lerner Research Institute,
    Cleveland Clinic Foundation, Cleveland, Ohio
  • Jinbo Liu
    Department of Cell Biology, Lerner Research Institute,
    Cleveland Clinic Foundation, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  Minzhong Yu, None; Weilin Zou, None; Neal S. Peachey, None; Thomas McIntyre, None; Jinbo Liu, None
  • Footnotes
    Support  AHAF Award M2008-063, Foundation Fighting Blindness Center Grant; Research to Prevent Blindness; VA Medical Research Service.
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1232. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Minzhong Yu, Weilin Zou, Neal S. Peachey, Thomas McIntyre, Jinbo Liu; A Role For Complement Activation In Preventing Retinal Degeneration. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1232.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The observations that single nucleotide polymorphisms of complement alternative pathway components are associated with the risk of AMD development indicate that complement plays an important role in AMD pathology. How these variants lead to photoreceptor degeneration is not known. To better understand the relationship between complement activation and the retina, we examined mice lacking the receptors for complement activation fragments C3a (C3aR-/-), C5a (C5aR-/-) or both (C3aR-/-/C5aR-/-).

Methods: : Complement mutant mice (C3aR-/-; C5aR-/-; C3aR-/-/C5aR-/-) were studied along with WT littermates from ages of 6 weeks up to 14 months. After overnight dark adaptation, strobe flash ERGs were used to examine outer retinal function and a dc-ERG technique was used to measures ERG components generated by the retinal pigment epithelium (RPE). Retinas were examined by immunohistochemistry and microscope.

Results: : C3aR was localized to the RPE and all cell layers of the neural retina; C5aR expression was restricted to the RPE and ganglion cell layer. We observed a progressive decline of ERG a- and b-wave amplitudes in C3aR-/- and C3aR-/-/C5aR-/-mice, which was correlated with cellular losses in the ONL and INL. These changes were not observed in C5aR-/- animals. Amplitude reductions were, however, noted in dc-ERGs recorded from C5aR-/- mice.

Conclusions: : Genetic deletion of receptors for the complement activation fragments C3a and C5a leads to cell-specific defects that match the cellular localization of these receptors in the WT retina. These indicate that receptor signaling through these pathways contribute to retinal cell survival.

Keywords: retinal degenerations: cell biology • electroretinography: non-clinical • receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×